Advertisement
News
Subscribe to MDT Magazine News

Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetac...

December 21, 2010 5:35 pm | by Bio-Medicine.Org | Comments

DEERFIELD, Ill. and OSAKA, Japan, Dec. 21, 2010 /- Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc. ("TPNA"), have completed settlements with all defendants in patent litigation brought...

TOPICS:

MiMedx Announces Agreement to Acquire Surgical Biologics

December 21, 2010 5:35 pm | by Bio-Medicine.Org | Comments

MARIETTA, Ga., Dec. 21, 2010 /- MiMedx Group, Inc. (OTC Bulletin Board: MDXG ), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has signed a definitive agreement to acquire Surgical Biologics, a leader in the...

TOPICS:

CEO Seeks to Make Connections With Hospitals

December 21, 2010 5:35 pm | by San Diego Business Journal | Comments

Growing market share in the year ahead is at the top of the priority list for Jay Deady, who on Dec. 1 was hired as president and chief executive officer at Awarepoint Corp., the San Diego-based provider of tracking systems for equipment and patients.

TOPICS:
Advertisement

Jazz Pharmaceuticals Announces New Patent Issued for Sodium Oxybate(2)

December 21, 2010 5:34 pm | by Bio-Medicine.Org | Comments

PALO ALTO, Calif., Dec. 21, 2010 /- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) today announced that the United States Patent and Trademark Office (USPTO) has issued a patent related to Xyrem® (sodium oxybate) oral solution titled "Microbiologically Sound and Stable Solutions of...

TOPICS:

Mesa Labs Acquires the Biological Indicators Business of Apex Laboratories, Inc.(2)

December 21, 2010 5:34 pm | by Bio-Medicine.Org | Comments

LAKEWOOD, Colo., Dec. 21, 2010 /- Mesa Laboratories, Inc. (Nasdaq: MLAB ), a Lakewood, Colorado based manufacturer of electronic instruments and disposables today announced the acquisition of the biological indicators business of Apex Laboratories, Inc., a North Carolina based company....

TOPICS:

Earlier initiation of antiretroviral therapy should be highest priority for expansion of HIV care

December 21, 2010 2:42 pm | by EurekAlert | Comments

(Public Library of Science) Earlier initiation of antiretroviral therapy should be the highest priority for global expansion of HIV patient care. This finding, from a paper published in this week's PLoS Medicine, should help resource-limited nations to phase in the implementation...

TOPICS:

Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA

December 21, 2010 2:37 pm | by Bio-Medicine.Org | Comments

SAN DIEGO, Dec. 21, 2010 /- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today that Jack Lief, Arena's President and Chief Executive Officer, will host a conference call and webcast tomorrow, Wednesday, December 22, 2010, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time) to...

TOPICS:

Jazz Pharmaceuticals Announces New Patent Issued for Sodium Oxybate

December 21, 2010 2:36 pm | Comments

PALO ALTO, Calif., Dec. 21, 2010 /- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) today announced that the United States Patent and Trademark Office (USPTO) has issued a patent related to Xyrem® (sodium oxybate) oral solution titled "Microbiologically Sound and Stable Solutions of...

Advertisement

Mesa Labs buys Apex biological indicators business(2)

December 21, 2010 10:46 am | by The Associated Press | Comments

Mesa Laboratories Inc. said Tuesday it acquired the biological indicators business of Apex Laboratories Inc. Terms of the deal were not disclosed.The Lakewood, Colo., company, which makes instruments and disposable products for healthcare and industrial applications, expects the deal to...

Avnet commemorates its 50th Anniversary on the New York Stock Exchange

December 21, 2010 10:46 am | by Avnet | Comments

Avnet commemorated its 50th anniversary as a publicly traded company on the New York Stock Exchange (NYSE) by ringing the Closing Bell on Wednesday, December 15, 2010.

Mesa Labs buys Apex biological indicators business

December 21, 2010 10:45 am | Comments

Mesa Laboratories Inc. said Tuesday it acquired the biological indicators business of Apex Laboratories Inc. Terms of the deal were not disclosed.The Lakewood, Colo., company, which makes instruments and disposable products for healthcare and industrial applications, expects the deal to...

TTI, Inc. Launches Interactive Holiday Trivia Contest

December 21, 2010 10:34 am | by TTI, Inc. | Comments

It's the holiday season and to celebrate TTI, Inc. is inviting its customers, suppliers and electronics industry employees to play its new, on-line holiday trivia game launched this week that features The Specialist, the new company spokesperson recently selected from The Big Job Campaign.

ISSYS awarded two grants for Its wireless, batteryless implants and drug infusion medical products under the therapeutic discovery project

December 21, 2010 10:32 am | by I-Micronews | Comments

Integrated Sensing Systems, Inc. (ISSYS) announces that it has received two federal grants to aid in the support of its wireless implantable pressure sensors for the chronic treatment of congestive heart failure, as well as its drug infusion flow sensing technology for much safer drug...

Premarket Approval (PMA) Summary Review Memos for 180-Day Design Changes

December 21, 2010 9:36 am | by U.S. Food & Drug Administration | Comments

A 180-day supplement is a request for a significant change in components, materials, design, specification, software, color additive, and labeling to an approved premarket application or premarket report.

Fresenius Kabi LLC, Red Blood Cell (RBC) Exchange Sets used on AS104 Blood Cell Separation Devices: Class I Recall

December 21, 2010 9:30 am | by U.S. Food & Drug Administration | Comments

Use of the recalled product has led to removal of greater amounts of red blood cells than intended, resulting in hemodilution.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading